Devens, MA, United States of America

Shazad Suchit

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Shazad Suchit: Innovator in Pharmaceutical Chemistry

Introduction

Shazad Suchit is a notable inventor based in Devens, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds aimed at treating various oxidative stress disorders. With a total of four patents to his name, his work is recognized for its potential impact on health and medicine.

Latest Patents

Among his latest patents, Shazad Suchit has developed polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide. These patents disclose polymorphic and amorphous forms of anhydrate, hydrate, and solvates of this compound. The methods outlined in these patents focus on using these compositions for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases, and diseases of aging. Furthermore, the patents detail methods for producing such polymorphic and amorphous forms.

Career Highlights

Shazad Suchit has worked with several prominent companies in the pharmaceutical sector. Notably, he has been associated with PTC Therapeutics, Inc. and Bioelectron Technology Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Shazad has collaborated with various professionals in his field, including notable coworkers such as Paul Mollard and Peter Giannousis. These collaborations have likely enriched his research and development efforts.

Conclusion

Shazad Suchit stands out as an influential inventor in the realm of pharmaceutical chemistry. His innovative work on polymorphic forms of compounds demonstrates his commitment to advancing medical science and improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…